HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pilar Martínez-Sánchez Selected Research

Methotrexate (Mexate)

10/2013First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pilar Martínez-Sánchez Research Topics

Disease

5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2024 - 06/2012
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2018 - 10/2017
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2023 - 06/2022
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2023 - 10/2021
2Neoplasms (Cancer)
01/2022 - 01/2018
2Residual Neoplasm
10/2021 - 12/2013
2Philadelphia Chromosome
01/2021 - 01/2018
2Multiple Myeloma
12/2013 - 09/2008
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Second Primary Neoplasms (Neoplasms, Second)
10/2017
1Melanoma (Melanoma, Malignant)
12/2013
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2013
1Pathologic Complete Response
10/2013
1Infections
06/2012
1Lymphoma (Lymphomas)
06/2012

Drug/Important Bio-Agent (IBA)

3Rituximab (Mabthera)FDA Link
01/2018 - 10/2013
1blinatumomabIBA
02/2024
1Genetic Markers (Genetic Marker)IBA
01/2023
1Tyrosine Kinase InhibitorsIBA
06/2022
1fms-Like Tyrosine Kinase 3IBA
06/2022
1Asparaginase (Elspar)FDA Link
01/2018
1pegaspargase (Oncaspar)FDA Link
01/2018
1Dihydrotachysterol (AT 10)IBA
10/2017
1ribonucleotide polymeraseIBA
12/2013
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2013
1Methotrexate (Mexate)FDA LinkGeneric
10/2013
1Clofarabine (Clolar)FDA Link
06/2012

Therapy/Procedure

6Drug Therapy (Chemotherapy)
05/2023 - 09/2008
6Therapeutics
01/2023 - 10/2013
3Stem Cell Transplantation
12/2018 - 10/2017
1Radiotherapy
01/2022
1Salvage Therapy
10/2021
1Homologous Transplantation
01/2021
1Hematopoietic Stem Cell Transplantation
01/2021
1Secondary Prevention
12/2018